Related Experiment Video
Updated: Aug 1, 2026
11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 18, 2011
[Drug utilization and recommended conditions for use in children]
I Danés Carreras1, A Vallano Ferraz, G de la Cruz Sugrañes
1Fundació Institut Català de Farmacología. Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona. Spain. id@icf.uab.es
Anales Espanoles De Pediatria
|December 7, 2002
Summary
Many drugs used in children are not recommended or lack clear usage guidelines, highlighting a need for better pediatric drug research and information sources. This impacts safe medication practices for children.
Area of Science:
- Pediatric Pharmacology
- Drug Utilization Research
- Evidence-Based Medicine
Context:
- Limited research and authorization for pediatric drug use internationally.
- Scarcity of comprehensive drug information for children.
Purpose:
- To assess pediatric drug use conditions and information source variability.
- To compare Spanish and North American drug catalog recommendations for pediatric use.
Summary:
- A retrospective study analyzed medication consumption in a pediatric hospital.
- A significant percentage of drugs used in children were not recommended or had unspecified use conditions.
- International catalog comparison revealed discrepancies in pediatric drug recommendations.
Impact:
- Highlights the need for improved pediatric drug research and accessible information.
- Emphasizes the importance of aligning regulatory practices with therapeutic needs and evidence.
- Underscores potential risks associated with unapproved or off-label drug use in pediatric patients.
Related Concept Videos
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...